Indegene Limited (NSE:INDGN)
India
· Delayed Price · Currency is INR 586.40
+5.30 (0.91%)
Jun 18, 2025, 3:29 PM IST
Indegene Revenue
In the fiscal year ending March 31, 2025, Indegene had annual revenue of 28.39B INR with 9.64% growth. Indegene had revenue of 7.56B in the quarter ending March 31, 2025, with 12.28% growth.
Revenue
28.39B
Revenue Growth
+9.64%
P/S Ratio
4.91
Revenue / Employee
6.83M
Employees
4,158
Market Cap
139.47B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |